Articles By Jack Cush, MD
Adalimumab FDA Approved for Hidradenitis Suppurativa
Abbvie announced on 9/10/15 that adalimumab (Humira) has been FDA approved for the treatment of moderate to severe hidradenitis suppurativa (HS) and is now the first and only FDA-approved therapy for adults with HS.
Read Article
FDA Warns of Bone Fracture Risk and Lower BMD with Diabetes Drug
The FDA has strengthened its warnings for the type 2 diabetes drug canagliflozin (Invokana, Invokamet) and the apparent increased risk of bone fractures, and added new information about decreased bone mineral density.
Read Article
Antibodies to 14-3-3η Found in Large Vessel Vasculitis
14-3-3η (eta) is a new test that may be useful in diagnosing patients with early rheumatoid arthritis. The test is 77% sensitive and 93% specific for RA and developers have found that antibodies against 14-3-3η may correlate with drug responsiveness.
Read Article
JIA Pathogenesis Related to Neutrophils and Epigenetics
Neutrophils are pivotal players in the innate immune response, but are seldom linked to the pathogenesis of inflammatory arthritis, including juvenile idiopathic inflammatory arthritis (JIA).
Read Article
High False Negative Rate with PFTs in Scleroderma
Researchers in Zurich studed 102 systemic sclerosis with serial PFTs and high-resolution computed tomography of the chest (HRCT). They found significant interstitial lung disease (ILD) by HRCT in 63 percent.
Read Article
Obesity Protects Men from Rheumatoid Arthritis
Researchers from Malmo, Sweden have analyzed data from 383 patients, taken from two population based health surveys with a total of 50,705 participants, and found there is a strong association between a high BMI in men and a lower risk of developing rheumatoid arthritis (RA).
Read Article
Higher Death Rates in Ankylosing Spondylitis
A nationwide study of 8600 ankylosing spondylitis (AS) patients from Sweden, compared survival to 40,460 controls between 2006-2012.
Read Article
A Winning Season*
Winning is everything – in football and in medicine. Rheumatologists have achieved many successes but still struggle to win against a handful of rheumatic foes. This retrospective examines past wins and losses and helps us to look ahead to a new season.
Read Article
Education of the Fibromyalgia Patient
This week's Daily Download is the fibromyalgia “packet” we give to our patients once they have been diagnosed with fibromyalgia.
Read Article
Overuse and Underuse of Osteoporosis Drugs
A population-based sudy 824 post-menopausal women ≥50 years old from Valencia, Spain was studied to estimate the percentage of women eligible for treatment, and the proportion of overuse and underuse of antiosteoporotic treatment according to highly-influentia
Read Article
